Furthermore, the combination of PEG-IFNα and PD-1 blockade significantly promotes T cell infiltration—particularly cytotoxic CD8+ T cells—into the tumor micro-environment, thereby improving the efficacy of PD-1 antibodies and prolonging survival in mice. Here, CD8A is linked to neoplasm.